Nathan Elias Jeffries
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nathan Elias Jeffries has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- David Brian Sykes
Massachusetts General Hospital, Boston, MA
16 shared publications - Ninib Baryawno
Division of Pediatric Oncology and Pediatric Surgery, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
15 shared publications - Akash Patnaik
University of Chicago, Chicago, IL
14 shared publications - Chin-Lee Wu
Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA
14 shared publications - Douglas M. Dahl
Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
14 shared publications - Hanyu Zhang
Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts
14 shared publications
Latest Publications
- Open Access
- 6 October 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-3
Tracking NF-kB activity across steady-state neutrophil maturation
- 6 October 2025
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-3
Open AccessTracking NF-kB activity across steady-state neutrophil maturation
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 3: Gating strategy for enrichment of TREM2+SPP1+ macrophages. Labels above the flow plots refer to the parent population in the percentages are of the parent gate.
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 3: Gating strategy for enrichment of TREM2+SPP1+ macrophages. Labels above the flow plots refer to the parent population in the percentages are of the parent gate.
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Table 1: Metadata for samples involved in this study
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Table 1: Metadata for samples involved in this study
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 6: Spatial architecture of tumor associated macrophages in prostate cancer.
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 6: Spatial architecture of tumor associated macrophages in prostate cancer.
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Data from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Tumor-associated macrophages (TAM) are a transcriptionally heterogeneous population, and their abundance and function in prostate cancer is poorly defined. We integrated parallel datasets from single-cell RNA sequencing, spatial transcriptomics, and multiplex immunofluorescence to reveal the dynamics of TAMs in primary and metastatic prostate cancer. Four TAM subpopulations were identified. Notably, one of these TAM subsets was defined by the co-expression of SPP1+ and TREM2+ and was significantly enriched in metastatic tumors. The SPP1+/TREM2+ TAMs were enriched in the metastatic tumor microenvironment in both human patient samples and murine models of prostate cancer. The abundance of these SPP1+/TREM2+ macrophages was associated with patient progression-free survival. Spatially, TAMs within prostate cancer bone metastases were highly enriched within the tumor region, consistent with their protumorigenic role. Blocking SPP1 in the RM1 prostate cancer mouse model led to improved efficacy of anti–PD-1 treatment and increased CD8+ T-cell infiltration in tumor. These findings suggest that targeting SPP1+ TAMs may offer a promising therapeutic strategy and potentially enhance the effects of immune checkpoint inhibition in advanced prostate cancer.Implications:This study expands our understanding of the diverse roles of macrophage populations in prostate cancer metastases and highlights new therapeutic targets.
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Tumor-associated macrophages (TAM) are a transcriptionally heterogeneous population, and their abundance and function in prostate cancer is poorly defined. We integrated parallel datasets from single-cell RNA sequencing, spatial transcriptomics, and multiplex immunofluorescence to reveal the dynamics of TAMs in primary and metastatic prostate cancer. Four TAM subpopulations were identified. Notably, one of these TAM subsets was defined by the co-expression of SPP1+ and TREM2+ and was significantly enriched in metastatic tumors. The SPP1+/TREM2+ TAMs were enriched in the metastatic tumor microenvironment in both human patient samples and murine models of prostate cancer. The abundance of these SPP1+/TREM2+ macrophages was associated with patient progression-free survival. Spatially, TAMs within prostate cancer bone metastases were highly enriched within the tumor region, consistent with their protumorigenic role. Blocking SPP1 in the RM1 prostate cancer mouse model led to improved efficacy of anti–PD-1 treatment and increased CD8+ T-cell infiltration in tumor. These findings suggest that targeting SPP1+ TAMs may offer a promising therapeutic strategy and potentially enhance the effects of immune checkpoint inhibition in advanced prostate cancer.Implications:This study expands our understanding of the diverse roles of macrophage populations in prostate cancer metastases and highlights new therapeutic targets.
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Table 4: Nano-string DSP spatial expression of proteins
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Table 4: Nano-string DSP spatial expression of proteins
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 2: Heterogeneity of tumor associated macrophage localized prostate cancer.
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 2: Heterogeneity of tumor associated macrophage localized prostate cancer.
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 1: Immune cell infiltration in localized prostate cancer.
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 1: Immune cell infiltration in localized prostate cancer.
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 4: A-B. Boxplot showing macrophage marker gene expression in TCGA (A) and GSE21034 (B) prostate cancer bulk RNAseq datasets.
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Supplementary Figure 4: A-B. Boxplot showing macrophage marker gene expression in TCGA (A) and GSE21034 (B) prostate cancer bulk RNAseq datasets.